Literature DB >> 15786491

Regulation of skeletal development by the Runx family of transcription factors.

Toshihisa Komori1.   

Abstract

The Runx (runt-related protein) family of transcription factors plays important roles in different tissues and cell lineages. Runx1 determines commitment to the hematopoietic cell lineage and Runx2 determines commitment to the osteoblastic lineage. Cbfbeta is required for Runx1- and Runx2-dependent transcriptional regulation. Runx2 interacts with many other transcription factors and co-regulators in the transcriptional regulation of its target genes. Runx2 is essential for the commitment of multipotent mesenchymal cells into the osteoblastic lineage and inhibits adipocyte differentiation. Runx2 induces the gene expression of bone matrix proteins, while keeping the osteoblastic cells in an immature stage. Runx2 and Runx3 have redundant functions in chondrocytes, and they are essential for chondrocyte maturation. Runx2 directly induces Indian hedgehog (Ihh) expression and co-ordinates the proliferation and differentiation of chondrocytes. Therefore, elucidation of the signaling pathways through Runx2 and Runx3 will unravel the complex mechanism of skeletal development. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786491     DOI: 10.1002/jcb.20420

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  96 in total

1.  Myeloma as a model for the process of metastasis: implications for therapy.

Authors:  Irene M Ghobrial
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

2.  Regulation of Tcf7 by Runx2 in chondrocyte maturation and proliferation.

Authors:  Masaki Mikasa; Satoshi Rokutanda; Hisato Komori; Kosei Ito; Ying Sze Tsang; Yuki Date; Carolina A Yoshida; Toshihisa Komori
Journal:  J Bone Miner Metab       Date:  2010-10-02       Impact factor: 2.626

3.  Runx3 negatively regulates Osterix expression in dental pulp cells.

Authors:  Li Zheng; Koichiro Iohara; Masaki Ishikawa; Takeshi Into; Teruko Takano-Yamamoto; Kenji Matsushita; Misako Nakashima
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

4.  Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation.

Authors:  Xing Zhong; Ling-ling Xiu; Guo-hong Wei; Yuan-yuan Liu; Lei Su; Xiao-pei Cao; Yan-bing Li; Hai-peng Xiao
Journal:  Acta Pharmacol Sin       Date:  2011-04-18       Impact factor: 6.150

5.  Dose-dependent effects of Runx2 on bone development.

Authors:  Shiqin Zhang; Zhousheng Xiao; Junming Luo; Nan He; Josh Mahlios; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

6.  Satb2 regulates proliferation and nuclear integrity of pre-osteoblasts.

Authors:  Todd Dowrey; Evelyn E Schwager; Julieann Duong; Fjodor Merkuri; Yuri A Zarate; Jennifer L Fish
Journal:  Bone       Date:  2019-07-17       Impact factor: 4.398

7.  Evolution of the interaction between Runx2 and VDR, two transcription factors involved in osteoblastogenesis.

Authors:  Sylvain Marcellini; Carola Bruna; Juan P Henríquez; Miguel Albistur; Ariel E Reyes; Elias H Barriga; Berta Henríquez; Martín Montecino
Journal:  BMC Evol Biol       Date:  2010-03-17       Impact factor: 3.260

8.  Loss of the putative catalytic domain of HDAC4 leads to reduced thermal nociception and seizures while allowing normal bone development.

Authors:  Indrani Rajan; Katerina V Savelieva; Gui-Lan Ye; Ching-Yun Wang; Murtaza M Malbari; Carl Friddle; Thomas H Lanthorn; Wandong Zhang
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

9.  Dlx5 Is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification.

Authors:  Hui Zhu; Andrew J Bendall
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

10.  Molecular pedomorphism underlies craniofacial skeletal evolution in Antarctic notothenioid fishes.

Authors:  R Craig Albertson; Yi-Lin Yan; Tom A Titus; Eva Pisano; Marino Vacchi; Pamela C Yelick; H William Detrich; John H Postlethwait
Journal:  BMC Evol Biol       Date:  2010-01-06       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.